Journal
KIDNEY INTERNATIONAL SUPPLEMENTS
Volume 12, Issue 1, Pages 7-11Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.kisu.2021.11.003
Keywords
chronic kidney disease; mortality; prevalence; risk factors
Categories
Funding
- Bayer AG
- Jo Luscombe, PhD, of Chameleon Communications International
Ask authors/readers for more resources
Chronic kidney disease affects over 800 million individuals worldwide, especially prevalent in older individuals, women, racial minorities, and people with diabetes and hypertension. It has become a major cause of mortality globally, particularly in low- and middle-income countries.
Chronic kidney disease is a progressive condition that affects >10% of the general population worldwide, amounting to >800 million individuals. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and in people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middleincome countries, which are least equipped to deal with its consequences. Chronic kidney disease has emerged as one of the leading causes of mortality worldwide, and it is one of a small number of non-communicable diseases that have shown an increase in associated deaths over the past 2 decades. The high number of affected individuals and the significant adverse impact of chronic kidney disease should prompt enhanced efforts for better prevention and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available